Chyung S. Cook

1.1k total citations
29 papers, 850 citations indexed

About

Chyung S. Cook is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Chyung S. Cook has authored 29 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Pharmacology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Chyung S. Cook's work include Pharmacogenetics and Drug Metabolism (8 papers), Hormonal Regulation and Hypertension (7 papers) and Ion Transport and Channel Regulation (4 papers). Chyung S. Cook is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Hormonal Regulation and Hypertension (7 papers) and Ion Transport and Channel Regulation (4 papers). Chyung S. Cook collaborates with scholars based in United States, Switzerland and Canada. Chyung S. Cook's co-authors include Aziz Karim, Susan K. Paulson, Bo Yan, Timothy J. Maziasz, Jeremy D. Hribar, Grant L. Schoenhard, Loren Berry, Liming Zhang, Barrett Rabinow and Roy H. Bible and has published in prestigious journals such as Blood, Hypertension and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Chyung S. Cook

28 papers receiving 810 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chyung S. Cook United States 13 268 206 200 171 153 29 850
Joan E. Staggers United States 12 211 0.8× 137 0.7× 364 1.8× 40 0.2× 61 0.4× 14 1.2k
R. Obach Spain 19 305 1.1× 170 0.8× 217 1.1× 79 0.5× 112 0.7× 60 1.1k
W. Roth Germany 10 52 0.2× 68 0.3× 114 0.6× 102 0.6× 227 1.5× 18 647
Nobuo Inotsume Japan 17 40 0.1× 194 0.9× 212 1.1× 243 1.4× 185 1.2× 90 1.1k
Vadlamani K. Prasad United States 17 195 0.7× 76 0.4× 132 0.7× 75 0.4× 76 0.5× 53 701
Xavier Boulenc France 15 109 0.4× 56 0.3× 198 1.0× 336 2.0× 78 0.5× 19 814
G. Heinzel Germany 16 58 0.2× 56 0.3× 156 0.8× 211 1.2× 391 2.6× 31 913
Timothy J. Maziasz United States 15 143 0.5× 47 0.2× 255 1.3× 220 1.3× 718 4.7× 21 1.4k
Lawrence S. Olanoff United States 17 162 0.6× 25 0.1× 123 0.6× 134 0.8× 141 0.9× 27 823
Teruyoshi Yokoyama Japan 21 87 0.3× 31 0.2× 315 1.6× 287 1.7× 96 0.6× 99 1.2k

Countries citing papers authored by Chyung S. Cook

Since Specialization
Citations

This map shows the geographic impact of Chyung S. Cook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chyung S. Cook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chyung S. Cook more than expected).

Fields of papers citing papers by Chyung S. Cook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chyung S. Cook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chyung S. Cook. The network helps show where Chyung S. Cook may publish in the future.

Co-authorship network of co-authors of Chyung S. Cook

This figure shows the co-authorship network connecting the top 25 collaborators of Chyung S. Cook. A scholar is included among the top collaborators of Chyung S. Cook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chyung S. Cook. Chyung S. Cook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cook, Chyung S.. (2011). Current Issues on Bioavailability and Bioequivalence Determination. Journal of Bioequivalence & Bioavailability. s1. 3 indexed citations
2.
Rabinow, Barrett, et al.. (2010). Nanosuspension Formulation of Itraconazole Eliminates the Negative Inotropic Effect of SPORANOX® in Dogs. Journal of Medical Toxicology. 6(3). 331–336. 12 indexed citations
3.
Rabinow, Barrett, James Kipp, Pavlos Papadopoulos, et al.. (2007). Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat. International Journal of Pharmaceutics. 339(1-2). 251–260. 125 indexed citations
4.
Shen, Lixin, John F. Fitzloff, & Chyung S. Cook. (2004). DIFFERENTIAL ENANTIOSELECTIVITY AND PRODUCT-DEPENDENT ACTIVATION AND INHIBITION IN METABOLISM OF VERAPAMIL BY HUMAN CYP3AS. Drug Metabolism and Disposition. 32(2). 186–196. 32 indexed citations
5.
Zhang, Ji Y., Jenny Zhan, Chyung S. Cook, R. M. J. Ings, & Alan P. Breau. (2003). Involvement of Human UGT2B7 and 2B15 in Rofecoxib Metabolism. Drug Metabolism and Disposition. 31(5). 652–658. 32 indexed citations
6.
Cook, Chyung S., et al.. (2003). PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS. Drug Metabolism and Disposition. 31(11). 1448–1455. 62 indexed citations
7.
Cook, Chyung S., Loren Berry, David H. Kim, et al.. (2002). Involvement of CYP3A in the Metabolism of Eplerenone in Humans and Dogs: Differential Metabolism by CYP3A4 and CYP3A5. Drug Metabolism and Disposition. 30(12). 1344–1351. 47 indexed citations
8.
Cook, Chyung S. & Liming Zhang. (2002). Atypical dose–route-dependent food effects of eplerenone in the dog: Presence of food effects following intravenous dosing and lack of food effects of following oral dosing. Journal of Pharmaceutical Sciences. 91(3). 607–614. 2 indexed citations
9.
Paulson, Susan K., et al.. (2001). Pharmacokinetics of Celecoxib after Oral Administration in Dogs and Humans: Effect of Food and Site of Absorption. Journal of Pharmacology and Experimental Therapeutics. 297(2). 638–645. 244 indexed citations
10.
Delyani, John A., Ricardo Rocha, Chyung S. Cook, et al.. (2001). Eplerenone: A Selective Aldosterone Receptor Antagonist (SARA). Cardiovascular Drug Reviews. 19(3). 185–200. 93 indexed citations
11.
Cook, Chyung S., et al.. (2000). Absorption and Disposition of a Selective Aldosterone Receptor Antagonist, Eplerenone, in the Dog. Pharmaceutical Research. 17(11). 1426–1431. 13 indexed citations
12.
Pao, Li‐Heng, Simon Zhou, Chyung S. Cook, et al.. (1998). Reduced Systemic Availability of an Antiarrhythmic Drug, Bidisomide, with Meal Co-administration: Relationship with Region-Dependent Intestinal Absorption. Pharmaceutical Research. 15(2). 221–227. 28 indexed citations
13.
Garthwaite, Susan M., Keitaro Hashimoto, Aziz Karim, et al.. (1995). Bidisomide: An Investigational Antiarrhythmic Agent. Cardiovascular Drug Reviews. 13(1). 19–32. 2 indexed citations
14.
Cook, Chyung S., et al.. (1995). Species Dependent Esterase Activities for Hydrolysis of an Anti-HIV Prodrug Glycovir and Bioavailability of Active SC-48334. Pharmaceutical Research. 12(8). 1158–1164. 27 indexed citations
15.
Cook, Chyung S., Grant L. Schoenhard, & Aziz Karim. (1994). Effect of Salicylic Acid on the Plasma Protein Binding and Pharmacokinetics of Misoprostol Acid. Journal of Pharmaceutical Sciences. 83(6). 883–886. 7 indexed citations
16.
Cook, Chyung S., et al.. (1993). Absorption and disposition of a new antiarrhythmic agent bidisomide in man.. Pharmaceutical Research. 10(11). 1675–1682. 10 indexed citations
17.
Garthwaite, Susan M., et al.. (1992). Electropharmacology of bidisomide in the normal intact canine heart. Drug Development Research. 27(4). 329–344. 4 indexed citations
18.
Garthwaite, Susan M., et al.. (1989). Efficacy and Plasma Concentrations of SC-36602 in Canine Models of Ventricular Arrhythmia. Journal of Cardiovascular Pharmacology. 13(2). 218–226. 6 indexed citations
19.
Garthwaite, Susan M., et al.. (1989). Actisomide. Cardiovascular Drug Reviews. 7(1). 52–67. 4 indexed citations
20.
Cook, Chyung S., Grant L. Schoenhard, Charles E. Piper, et al.. (1988). Difference in metabolic profile of potassium canrenoate and spironolactone in the rat: Mutagenic metabolites unique to potassium canrenoate. Archives of Toxicology. 61(3). 201–212. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joan E. Staggers Breakdown of academic impact, for papers by R. Obach Breakdown of academic impact, for papers by W. Roth Breakdown of academic impact, for papers by Nobuo Inotsume Breakdown of academic impact, for papers by Vadlamani K. Prasad Breakdown of academic impact, for papers by Xavier Boulenc Breakdown of academic impact, for papers by G. Heinzel Breakdown of academic impact, for papers by Timothy J. Maziasz Breakdown of academic impact, for papers by Lawrence S. Olanoff Breakdown of academic impact, for papers by Teruyoshi Yokoyama
Rankless by CCL
2026